2022 AF Symposium: Pulsed Field Ablation Systems
At A-Fib.com, we first described the new technology called Pulsed Field Ablation (Farapulse, Inc.) in the beginning of 2021. See my report: Pulse Field Ablation—Emerging Tech for Atrial Fibrillation. Since then, Farapulse, Inc. has been acquired by Boston Scientific.
Today many companies with different Pulse Field Ablation systems have entered the market. All are still in various stages of investigation, none have been FDA approved.
In my report, In Development: Systems for Pulsed Field Ablation (PFA), I summarize comments by Dr. Moussa Mansour of Massachusetts General Hospital in Boston, MA, in his presentation, “Technology and Regulatory Status of Current Systems for Pulsed Field Ablation (PFA).”
He gave an overview of the various companies and their PFA systems in development and in clinical trials. You’ll find my 2022 AF Symposium report here: Pulsed Field Ablation. You can also see my other reports at 2022 AF Symposium.